KTTA - Pasithea Therapeutics Corp
0.7965
0.006 0.816%
Share volume: 82,290
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.14%
PREVIOUS CLOSE
CHG
CHG%
$0.79
0.01
0.01%
Summary score
37%
Profitability
43%
Dept financing
20%
Liquidity
58%
Performance
30%
Sector
Manufacturing
Industry
Pharmaceutical Products/Pharmaceutical Preparations
Long-term ratios 30-Sep-2021 - 30-Sep-2025
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-8.93%
Return on assets
-14.24%
Return on sales
-11085.01%
Return on invested capital
17.62%
Total debt ratio
7.06%
Debt ratio change over timeo
-1.09%
Current Ratio
22.64%
Quick Ratio
36.22%
Cash Position Ratio
21.93%
Short-term ratios 30-Sep-2024 - 30-Sep-2025
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
-23.07%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
9.96%
Debt ratio change over timeo
0%
Current Ratio
4.81%
Quick Ratio
0%
Cash Position Ratio
4.17%
Last quarter ratios 30-Sep-2025
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
-22.6%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
10.45%
Debt ratio change over time
0%
Current Ratio
4.02%
Quick Ratio
0%
Cash Position Ratio
2.99%
Performance ratios (change over 4 years) 30-Sep-2021 - 30-Sep-2025
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-84.9%
Return on assets
-86.07%
Return on sales
-164.44%
Return on invested capital
-19.74%
Total debt ratio
-109.39%
Debt ratio change over time
-1.09%
Current Ratio
-21.29%
Quick Ratio
-21.29%
Cash Position Ratio
-20.32%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | KTTA | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | -8.93% | 13.23% | 9.84% | 26.17% |
| Return on assets | -14.24% | 4.59% | 3.2% | 1.81% |
| Return on sales | -11085.01% | 30.04% | 25.15% | 24.65% |
| Return on invested capital | 17.62% | 8.51% | 10.28% | 4.83% |
| Profitability | 25% | 75% | 62% | 62% |
| Total debt ratio | 7.06% | 80.7% | 59.39% | 93.28% |
| Debt ratio change over time | -1.09% | -16.59% | -73.52% | 21.11% |
| Dept financing | 2% | 22% | 16% | 50% |
| Current Ratio | 4.81% | 1.34% | 1.11% | 0.72% |
| Quick Ratio | 0% | 1.05% | 0.86% | 0.6% |
| Cash Position Ratio | 4.17% | 0.14% | 0.46% | 0.15% |
| Liquididy | 75% | 2% | 3% | 2% |
| Short-term ratios | KTTA | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | 0% | 0% | 0% | 0% |
| Return on assets | -23.07% | 5.82% | 4.08% | 0.78% |
| Return on sales | 0% | 38.27% | 25.36% | 15.48% |
| Return on invested capital | 0% | 0% | 0% | 0% |
| Profitability | 50% | 50% | 34% | 13% |
| Total debt ratio | 9.96% | 81.38% | 59.57% | 99.65% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 27% | 20% | 15% | 25% |
| Current Ratio | 4.81% | 1.34% | 1.11% | 0.72% |
| Quick Ratio | 0% | 1.05% | 0.86% | 0.6% |
| Cash Position Ratio | 4.17% | 0.14% | 0.46% | 0.15% |
| Liquididy | 50% | 33% | 29% | 19% |